Compugen
Dr. Howard Soule is a world leader in the field of prostate cancer. As Chief Science Officer at the Prostate Cancer Foundation, Dr. Soule coordinates global academic, government and biopharmaceutical sector research activity and is responsible for the implementation of Prostate Cancer Foundation global research strategies. He is also a member of the Department of Defense Prostate Cancer Research Program Integration Panel. Dr. Soule received his Ph.D. from Baylor College of Medicine in virology and epidemiology and was a postdoctoral fellow in immunology and vascular biology at the Scripps Research Institute. Dr. Soule has substantial R&D and business development experience in the biopharmaceutical and diagnostics industries.
This person is not in the org chart
This person is not in any offices
Compugen
1 followers
Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange.